top of page
Airplane Above the Clouds

TRAVEL CERTIFICATES FOR EVERY DESTINATION

Why saliva based testing

> Pain and discomfort free

> No contact sampling for enhanced safety

> Self sampling, reducing/eliminating testing queues

> Rapid processing for client convenience

> As accurate as nasal/oral swabs 

Saliva collection.jpeg

> Enables large scale testing due to self collection

> Enables testing of young children without discomfort

> Implementation in UK, New Zealand, India & Australia (news links below)

> Covid surveillance in essential workers, Australia (Sept 2021)

> UK laws updated to include saliva testing  (June 2021)

> Mandatory testing essential workers New Zealand  (May 2021)

> Testing of summer Olympic athletes in Japan (Apr 2021)

> Rapid antigen saliva vs RT-PCR tests in India (Mar 2021)

> First implementation in Australia (June 2020)

saliva icon_5.png

> Widely implemented in USA since mid 2020 (news links below)

> Implementation in Los Angeles, USA increases (Oct 2020)

> SalivaDirect, developed by Yale University (Aug 2020)

> Federal Drug Administration Approved since Aug 2020

> Enabling safer sporting events for NBA basketball players (Aug 2020)

> Launched for use in New York hospital (April 2021)

> Detection of Delta variant using saliva testing (Aug 2021)

> Test efficacy supported by clinical trials (Aug 2021)

> Outperformance of commercial swab testing (Sept 2021)

grey waves.png

Several peer reviewed scientific studies have compared nasopharyngeal swabs and saliva samples in confirmed COVID-19 patients and healthcare workers.

 

The studies found that:

​

  • Using saliva for COVID-19 detection is more sensitive and consistent than using nasopharyngeal swabs.

​​

  • Less variability occurred in sample collection of saliva.

​

  • COVID-19 was detected in the saliva of asymptomatic healthcare workers, whereas COVID-19 was not detected from nasopharyngeal swabs in the same workers.

​​The literature detailed below shows that saliva is a reliable sample and more sensitive than nasopharyngeal swabs.


1.     To, K. K-W. et al. Consistent Detection of 2019 Novel Coronavirus in Saliva. Clin Infect DIs. (2020) doi: 10.1093/cid/ciaa149.

2.     Kojima, N. et al. Self-Collected Oral Fluid and Nasal Swabs Demonstrate Comparable Sensitivity to Clinician Collected Nasopharyngeal Swabs for COVID-19 Detection. medRxiv 2020.04.11.20062372 (2020).

3.     U.S. Food & Drug Administration. Accelerated Emergency Use Authorization (EUA) Summary SARS-CoV-2 Assay (Rutgers Clinical Genomics Laboratory)

4.      CDC. Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html (2020).

bottom of page